Molecular targeted therapy causes hepatic encephalopathy in patients after Transjugular intrahepatic portosystemic shunt (TIPS): A case report and literature review

We report two cases of hepatic encephalopathy caused by molecular targeted drugs after the Transjugular intrahepatic portosystemic shunt (TIPS) procedure in our center. The liver toxicities and anti-angiogenic effects induced by targeted drugs may generate an imbalance in ammonia metabolism, elevati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chen, Chen, Yang, Liu, Jiacheng, Shi, Qin, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Journal of Interventional Radiology Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947988/
https://www.ncbi.nlm.nih.gov/pubmed/35586281
http://dx.doi.org/10.1016/j.jimed.2021.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947988/
https://www.ncbi.nlm.nih.gov/pubmed/35586281
http://dx.doi.org/10.1016/j.jimed.2021.12.006

Ejemplares similares